Immunotherapy in small bowel adenocarcinoma: a potential role?

被引：2
作者：
Vitiello, Francesco [1 ]
Cereda, Stefano [1 ]
Foti, Silvia [1 ]
Liscia, Nicole [1 ]
Mazza, Elena [1 ]
Ronzoni, Monica [1 ]
Cascinu, Stefano [1 ]
机构：
[1] Univ Vita Salute San Raffaele, Dept Med Oncol, Comprehens Canc Ctr, Osped San Raffaele, Milan, Italy
来源：
IMMUNOLOGICAL MEDICINE | 2024年 / 47卷 / 01期
关键词：
Small bowel cancer; metastatic cancer; predictive markers; PDL-1; MSI; TMB; duodenal cancer; jejunal cancer; ileum tumor; CANCER;
D O I：
10.1080/25785826.2023.2220938
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Small bowel adenocarcinoma (SBA) is a rare tumor with an unfavorable prognosis, and due to its rarity, few studies on its treatment are available. Chemotherapy remains the standard of treatment in advanced disease. Recently immunotherapy has demonstrated to be a valid therapeutic option for many solid tumors. We reviewed the data published in literature to understand the impact of immunotherapy in this cancer.
引用
收藏
页码：1 / 5
页数：5
相关论文
共 50 条
  • [41] Advanced small bowel adenocarcinoma: Molecular characteristics and therapeutic perspectives
    Zaaimi, Yosra
    Aparicio, Thomas
    Laurent-Puig, Pierre
    Taieb, Julien
    Zaanan, Aziz
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2016, 40 (02) : 154 - 160
  • [42] Small bowel adenocarcinoma of the jejunum: a case report and literature review
    Li, Jie
    Wang, Zhiliang
    Liu, Na
    Hao, Junfeng
    Xu, Xin
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2016, 14
  • [43] A Rare Case of Small Bowel Obstruction in Pregnancy Due to Adenocarcinoma
    Almulhim, Zainab
    Othman, Sharifah
    Alarfaj, Mosab
    Hamadah, Nasreen
    Bamalan, Omar
    Alanazi, Faris
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (01)
  • [44] Second-line Chemotherapy for Previously Treated Metastatic Small Bowel Adenocarcinoma: A Retrospective Analysis
    Nakazawa, Taiko
    Narita, Yukiya
    Kumanishi, Ryosuke
    Ogata, Takatsugu
    Matsubara, Yuki
    Nozawa, Kazuki
    Kato, Kyoko
    Honda, Kazunori
    Masuishi, Toshiki
    Bando, Hideaki
    Kadowaki, Shigenori
    Ando, Masashi
    Hara, Kazuo
    Tajika, Masahiro
    Muro, Kei
    ANTICANCER RESEARCH, 2021, 41 (10) : 5147 - 5155
  • [45] The role of immunotherapy in small cell lung cancer
    Calles, A.
    Aguado, G.
    Sandoval, C.
    Alvarez, R.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (08) : 961 - 976
  • [46] The role of immunotherapy in small cell lung cancer
    A. Calles
    G. Aguado
    C. Sandoval
    R. Álvarez
    Clinical and Translational Oncology, 2019, 21 : 961 - 976
  • [47] WFDC2 is a potential prognostic and immunotherapy biomarker in lung adenocarcinoma
    Min, Bo
    Wang, Yan
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2024, 52 (07)
  • [48] Potential predictors of immunotherapy in small cell lung cancer
    Skopelidou, Valeria
    Strakos, Jan
    Skarda, Jozef
    Raska, Milan
    Kafkova-Raskova, Leona
    PATHOLOGY & ONCOLOGY RESEARCH, 2023, 29
  • [49] Genetics and epigenetics of small bowel adenocarcinoma: the interactions of CIN, MSI, and CIMP
    Warth, Arne
    Kloor, Matthias
    Schirmacher, Peter
    Blaeker, Hendrik
    MODERN PATHOLOGY, 2011, 24 (04) : 564 - 570
  • [50] SMALL BOWEL ADENOCARCINOMA ARISING IN LONGSTANDING FIBROSTENOTIC CROHN'S DISEASE
    Dumitrescu, D.
    Dumitru, A.
    Dimienescu, Alexandra
    Badiu, C. D.
    Dumitrescu, V
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2021, 125 (01): : 123 - 131
12345